| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 26 |
| 1 | METHOTREXATE SODIUM | 22 |
| 2 | DOXORUBICIN | 20 |
| 3 | METHOTREXATE | 20 |
| 4 | PAZOPANIB HYDROCHLORIDE | 16 |
| 5 | PAZOPANIB | 15 |
| 6 | ETOPOSIDE | 14 |
| 7 | REGORAFENIB | 11 |
| 8 | IFOSFAMIDE | 10 |
| 9 | IFOSFAMIDE FOR INJECTION | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPHEDRINE SULFATE | 1 | 0.0046 |
| 1 | DEXRAZOXANE FOR INJECTION | 3 | 0.0032 |
| 2 | GLUCARPIDASE | 1 | 0.0028 |
| 3 | GRANULOCYTE COLONY STIMULATING FACTOR | 3 | 0.0014 |
| 4 | AMIFOSTINE | 1 | 0.0012 |
| 5 | DINUTUXIMAB | 1 | 0.0012 |
| 6 | REGORAFENIB | 11 | 0.0009 |
| 7 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 8 | PAZOPANIB HYDROCHLORIDE | 16 | 0.0006 |
| 9 | ETOMIDATE INJECTION | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 2 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 3 | Topoisomerase Inhibitor [EPC] | 16 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 29 | 0.0001 |
| 7 | Phenothiazine [EPC] | 2 | 0.0001 |
| 8 | Alkylating Drug [EPC] | 16 | 0.0001 |
| 9 | Anticholinergic [EPC] | 1 | 0.0001 |